These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 19191299)

  • 21. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and new treatments.
    Brugha RE; Davies JC
    Br J Hosp Med (Lond); 2011 Nov; 72(11):614-9. PubMed ID: 22083001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [What microbiological criteria define a colonization or an infection with Pseudomonas aeruginosa?].
    Plésiat P
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S84-9. PubMed ID: 12910139
    [No Abstract]   [Full Text] [Related]  

  • 23. Microbial pathogenesis and biofilm development.
    Reisner A; Høiby N; Tolker-Nielsen T; Molin S
    Contrib Microbiol; 2005; 12():114-131. PubMed ID: 15496779
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical criteria of infection with Staphylococcus aureus and Pseudomonas aeruginosa].
    Brémont F
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S57-61. PubMed ID: 12910135
    [No Abstract]   [Full Text] [Related]  

  • 25. Eradication of early Pseudomonas infection in cystic fibrosis.
    Lee TW
    Chron Respir Dis; 2009; 6(2):99-107. PubMed ID: 19411571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease surveillance using bronchoalveolar lavage.
    Brennan S; Gangell C; Wainwright C; Sly PD
    Paediatr Respir Rev; 2008 Sep; 9(3):151-9. PubMed ID: 18694706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis.
    Lamont IL; Konings AF; Reid DW
    Biometals; 2009 Feb; 22(1):53-60. PubMed ID: 19130260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN; Ratjen F
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [What previous deductions can be used for optimizing analysis of bronchial secretions in cystic fibrosis?].
    Pin I; Pilenko C; Gout JP; Bost M
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S63-7. PubMed ID: 12910136
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk assessment of Pseudomonas aeruginosa in water.
    Mena KD; Gerba CP
    Rev Environ Contam Toxicol; 2009; 201():71-115. PubMed ID: 19484589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cystic fibrosis infections: treatment strategies and prospects.
    George AM; Jones PM; Middleton PG
    FEMS Microbiol Lett; 2009 Nov; 300(2):153-64. PubMed ID: 19674113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pseudomonas aeruginosa (Bacterium pyocyaneum) infection].
    Wöckel W
    Ergeb Allg Pathol Pathol Anat; 1967; 48():102-70. PubMed ID: 4960402
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of CFTR, Pseudomonas aeruginosa and Toll-like receptors in cystic fibrosis lung inflammation.
    Buchanan PJ; Ernst RK; Elborn JS; Schock B
    Biochem Soc Trans; 2009 Aug; 37(Pt 4):863-7. PubMed ID: 19614608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease.
    Murphy TF
    Curr Opin Pulm Med; 2009 Mar; 15(2):138-42. PubMed ID: 19532029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous manifestations due to Pseudomonas infection.
    Silvestre JF; Betlloch MI
    Int J Dermatol; 1999 Jun; 38(6):419-31. PubMed ID: 10397580
    [No Abstract]   [Full Text] [Related]  

  • 36. Pseudomonas aeruginosa biofilms in a bronchoalveolar lavage.
    Pusztaszeri M; Aubert JD; Braunschweig R; Mihaescu A
    Diagn Cytopathol; 2009 Nov; 37(11):825. PubMed ID: 19191299
    [No Abstract]   [Full Text] [Related]  

  • 37. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
    Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
    Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basic science for the chest physician: Pseudomonas aeruginosa and the cystic fibrosis airway.
    Williams HD; Davies JC
    Thorax; 2012 May; 67(5):465-7. PubMed ID: 22382597
    [No Abstract]   [Full Text] [Related]  

  • 39. [How should initial colonization by Pseudomonas aeruginosa be treated in patients with cystic fibrosis?].
    David V
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S113-7. PubMed ID: 12910143
    [No Abstract]   [Full Text] [Related]  

  • 40. [Respiratory infection in cystic fibrosis: burden of illness in the progression of cystic fibrosis, previous deductions for the microbiological study of bronchial secretions and clinical criteria of infection].
    Thumerelle C
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S37-48. PubMed ID: 12910133
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.